United American Healthcare Corporation (UAHC)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2013 | 8.48 Million USD | 24.27% |
| 2012 | 6.83 Million USD | -18.21% |
| 2011 | 8.35 Million USD | 118.75% |
| 2010 | 3.81 Million USD | -77.08% |
| 2009 | 16.65 Million USD | -40.94% |
| 2008 | 28.2 Million USD | 56.15% |
| 2007 | 18.06 Million USD | -0.27% |
| 2006 | 18.11 Million USD | -17.96% |
| 2005 | 22.07 Million USD | -0.02% |
| 2004 | 22.08 Million USD | -9.97% |
| 2003 | 24.53 Million USD | -86.38% |
| 2002 | 180.11 Million USD | 39.2% |
| 2001 | 129.39 Million USD | 23.3% |
| 2000 | 104.94 Million USD | 12.24% |
| 1999 | 93.5 Million USD | -11.46% |
| 1998 | 105.6 Million USD | -4.43% |
| 1997 | 110.5 Million USD | 7.28% |
| 1996 | 103 Million USD | 54.19% |
| 1995 | 66.8 Million USD | 51.47% |
| 1994 | 44.1 Million USD | 52.07% |
| 1993 | 29 Million USD | -14.45% |
| 1992 | 33.9 Million USD | -4.78% |
| 1991 | 35.6 Million USD | 42.97% |
| 1990 | 24.9 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 Q2 | 3.82 Million USD | 21.73% |
| 2018 Q1 | 3.13 Million USD | 0.0% |
| 2018 Q3 | 4.33 Million USD | 13.43% |
| 2018 Q4 | 4.27 Million USD | -1.36% |
| 2017 Q3 | 2676.00 USD | 0.0% |
| 2016 Q3 | 2171.00 USD | 0.0% |
| 2014 Q2 | 2.14 Million USD | 31.29% |
| 2014 Q1 | 1.63 Million USD | 0.0% |
| 2014 Q3 | 2.09 Million USD | -2.29% |
| 2013 Q3 | 1.82 Million USD | -24.94% |
| 2013 Q2 | 2.43 Million USD | 9.21% |
| 2013 Q1 | 2.22 Million USD | 15.64% |
| 2013 FY | 8.48 Million USD | 24.27% |
| 2012 Q2 | 2.02 Million USD | 23.33% |
| 2012 Q4 | 1.92 Million USD | 0.73% |
| 2012 FY | 6.83 Million USD | -18.21% |
| 2012 Q1 | 1.64 Million USD | 14.58% |
| 2012 Q3 | 1.91 Million USD | -5.68% |
| 2011 Q1 | 2.16 Million USD | -1.73% |
| 2011 FY | 8.35 Million USD | 118.75% |
| 2011 Q4 | 1.43 Million USD | -17.22% |
| 2011 Q3 | 1.73 Million USD | -7.38% |
| 2011 Q2 | 1.86 Million USD | -13.63% |
| 2010 FY | 3.81 Million USD | -77.08% |
| 2010 Q3 | 2.11 Million USD | 517.2% |
| 2010 Q2 | 343 Thousand USD | 2350.0% |
| 2010 Q1 | 14 Thousand USD | -99.18% |
| 2010 Q4 | 2.2 Million USD | 4.02% |
| 2009 Q2 | 3.25 Million USD | 24.43% |
| 2009 Q4 | 1.7 Million USD | -3.35% |
| 2009 Q3 | 1.76 Million USD | -45.85% |
| 2009 Q1 | 2.61 Million USD | -45.42% |
| 2009 FY | 16.65 Million USD | -40.94% |
| 2008 Q3 | 6.49 Million USD | -3.05% |
| 2008 Q2 | 6.69 Million USD | -19.07% |
| 2008 Q1 | 8.27 Million USD | 17.41% |
| 2008 FY | 28.2 Million USD | 56.15% |
| 2008 Q4 | 4.78 Million USD | -26.29% |
| 2007 Q3 | 6.18 Million USD | 20.91% |
| 2007 Q2 | 5.11 Million USD | 12.48% |
| 2007 Q4 | 7.04 Million USD | 13.9% |
| 2007 FY | 18.06 Million USD | -0.27% |
| 2007 Q1 | 4.55 Million USD | 7.74% |
| 2006 Q3 | 4.17 Million USD | -13.69% |
| 2006 FY | 18.11 Million USD | -17.96% |
| 2006 Q1 | 4.27 Million USD | -4.72% |
| 2006 Q2 | 4.83 Million USD | 13.02% |
| 2006 Q4 | 4.22 Million USD | 1.17% |
| 2005 FY | 22.07 Million USD | -0.02% |
| 2005 Q1 | 5.57 Million USD | 3.22% |
| 2005 Q2 | 5.69 Million USD | 2.26% |
| 2005 Q4 | 4.49 Million USD | -0.36% |
| 2005 Q3 | 4.5 Million USD | -20.92% |
| 2004 FY | 22.08 Million USD | -9.97% |
| 2004 Q4 | 5.39 Million USD | -0.17% |
| 2004 Q3 | 5.4 Million USD | 1.46% |
| 2004 Q2 | 5.33 Million USD | -3.91% |
| 2004 Q1 | 5.54 Million USD | 7.31% |
| 2003 Q4 | 5.16 Million USD | -9.76% |
| 2003 Q2 | 4.66 Million USD | -1.14% |
| 2003 Q1 | 4.71 Million USD | -41.35% |
| 2003 FY | 24.53 Million USD | -86.38% |
| 2003 Q3 | 5.72 Million USD | 22.84% |
| 2002 Q1 | 45.33 Million USD | 17.22% |
| 2002 Q2 | 55.11 Million USD | 21.56% |
| 2002 Q3 | 9.68 Million USD | -82.43% |
| 2002 Q4 | 8.04 Million USD | -16.96% |
| 2002 FY | 180.11 Million USD | 39.2% |
| 2001 Q1 | 34.01 Million USD | 2.03% |
| 2001 Q3 | 41.57 Million USD | 33.14% |
| 2001 Q4 | 38.67 Million USD | -6.97% |
| 2001 FY | 129.39 Million USD | 23.3% |
| 2001 Q2 | 31.22 Million USD | -8.2% |
| 2000 Q1 | 26.73 Million USD | 6.11% |
| 2000 Q4 | 33.34 Million USD | 9.74% |
| 2000 FY | 104.94 Million USD | 12.24% |
| 2000 Q2 | 28.23 Million USD | 5.61% |
| 2000 Q3 | 30.38 Million USD | 7.6% |
| 1999 Q3 | 24.8 Million USD | -9.16% |
| 1999 FY | 93.5 Million USD | -11.46% |
| 1999 Q4 | 25.2 Million USD | 1.61% |
| 1999 Q1 | 22.7 Million USD | 5.09% |
| 1999 Q2 | 27.3 Million USD | 20.26% |
| 1998 Q2 | 24.3 Million USD | -6.54% |
| 1998 Q3 | 21.9 Million USD | -9.88% |
| 1998 Q4 | 21.6 Million USD | -1.37% |
| 1998 FY | 105.6 Million USD | -4.43% |
| 1998 Q1 | 26 Million USD | -9.41% |
| 1997 Q2 | 13 Million USD | -60.73% |
| 1997 FY | 110.5 Million USD | 7.28% |
| 1997 Q3 | 26.5 Million USD | 103.85% |
| 1997 Q1 | 33.1 Million USD | 7.12% |
| 1997 Q4 | 28.7 Million USD | 8.3% |
| 1996 FY | 103 Million USD | 54.19% |
| 1996 Q4 | 30.9 Million USD | -8.04% |
| 1996 Q3 | 33.6 Million USD | -20.0% |
| 1996 Q2 | 42 Million USD | 51.08% |
| 1996 Q1 | 27.8 Million USD | 80.52% |
| 1995 Q2 | 16.1 Million USD | -9.55% |
| 1995 FY | 66.8 Million USD | 51.47% |
| 1995 Q4 | 15.4 Million USD | -11.49% |
| 1995 Q3 | 17.4 Million USD | 8.07% |
| 1995 Q1 | 17.8 Million USD | 6.59% |
| 1994 Q2 | 14.8 Million USD | 40.95% |
| 1994 Q1 | 10.5 Million USD | 11.7% |
| 1994 FY | 44.1 Million USD | 52.07% |
| 1994 Q4 | 16.7 Million USD | 2.45% |
| 1994 Q3 | 16.3 Million USD | 10.14% |
| 1993 Q1 | 6.9 Million USD | 4.55% |
| 1993 FY | 29 Million USD | -14.45% |
| 1993 Q4 | 9.4 Million USD | -2.08% |
| 1993 Q3 | 9.6 Million USD | 10.34% |
| 1993 Q2 | 8.7 Million USD | 26.09% |
| 1992 Q1 | 8.8 Million USD | -3.3% |
| 1992 Q2 | 7.3 Million USD | -17.05% |
| 1992 Q3 | 6.8 Million USD | -6.85% |
| 1992 FY | 33.9 Million USD | -4.78% |
| 1992 Q4 | 6.6 Million USD | -2.94% |
| 1991 Q3 | 8.7 Million USD | -4.4% |
| 1991 Q1 | 9 Million USD | 1.12% |
| 1991 Q2 | 9.1 Million USD | 1.11% |
| 1991 FY | 35.6 Million USD | 42.97% |
| 1991 Q4 | 9.1 Million USD | 4.6% |
| 1990 FY | 24.9 Million USD | 0.0% |
| 1990 Q2 | 6.3 Million USD | 1.61% |
| 1990 Q4 | 8.9 Million USD | 1.14% |
| 1990 Q1 | 6.2 Million USD | 0.0% |
| 1990 Q3 | 8.8 Million USD | 39.68% |
| 1989 Q3 | 6.2 Million USD | 0.0% |
| 1989 Q4 | 6.2 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | 714.7 Thousand USD | 100.0% |
| IR-Med Inc. | - USD | NaN% |
| Polarean Imaging plc | 890.93 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 100.0% |
| Avitar, Inc. | 3.1 Million USD | 100.0% |
| AVITA Medical, Inc. | 50.56 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | - USD | NaN% |
| Össur hf. | 785.68 Million USD | 100.0% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | 100.0% |
| QHSLab, Inc. | 1.4 Million USD | 100.0% |
| Wellstar International, Inc. | - USD | NaN% |
| Össur hf. | 785.68 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 100.0% |
| Escalon Medical Corp. | 11.98 Million USD | 100.0% |
| Aurora Spine Corporation | 14.52 Million USD | 100.0% |
| BrainsWay Ltd. | 31.78 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 257.39 Thousand USD | 100.0% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 100.0% |
| Vivos Inc. | 19.5 Thousand USD | 100.0% |
| MicroPort Scientific Corporation | 950.72 Million USD | 100.0% |
| Kelyniam Global, Inc. | 2.67 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | 100.0% |
| Nanomix Corporation | 15.45 Thousand USD | 100.0% |
| Theraclion SA | 1.82 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 100.0% |
| Positron Corporation | 734.66 Thousand USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 100.0% |
| Lombard Medical, Inc. | 12.16 Million USD | 100.0% |
| ALR Technologies Inc. | 7468.00 USD | 100.0% |
| Stratec SE | 289.14 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.46 Million USD | 100.0% |
| Heart Tronics, Inc. | - USD | NaN% |
| Nu-Med Plus, Inc. | - USD | NaN% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 71.70 USD | 100.0% |
| Guided Therapeutics, Inc. | 98 Thousand USD | 100.0% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | - USD | NaN% |
| ECGI Holdings, Inc. | - USD | NaN% |
| Capital Group Holdings, Inc. | - USD | NaN% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 100.0% |
| Urologix, Inc. | 14.23 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | NaN% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 100.0% |
| SS Innovations International, Inc. | 5.87 Million USD | 100.0% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | 100.0% |
| Smith & Nephew plc | 5.68 Billion USD | 100.0% |
| NIOX Group Plc | 46.84 Million USD | 100.0% |
| Fuse Medical, Inc. | 16.11 Million USD | 100.0% |
| Broncus Holding Corporation | 10.25 Million USD | 100.0% |
| Brain Scientific Inc. | 214.56 Thousand USD | 100.0% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 100.0% |
| Health Logic Interactive Inc. | - USD | NaN% |